Need Help?

ENU-NCI-H508 cetuximab fixed concentration project

Cetuximab is a targeted monoclonal antibody against the epidermal growth factor receptor (EGFR) which is used therapeutically for the treatment of KRAS wild-type colorectal cancer (CRC). The Cetuximab sensitive KRAS wild-type CRC cell line NCI-H508 has been treated with a fixed concentration of ENU for 24 hours and then selected with Cetuximab until drug resistant clones were ready to be picked and grown up as sub-clones of the parental cell line. These will have genes causally implicated in cancer sequenced to identify common point mutations in multiple independently derived drug resistant clones as a forward genetic screen for mechanisms of resistance to Cetuximab in CRC

Request Access

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001001744 Cancer Genomics

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00001110317 cram 2.5 GB
EGAF00001110318 cram 2.3 GB
EGAF00001110319 cram 2.2 GB
EGAF00001110320 cram 2.2 GB
EGAF00001110321 cram 2.2 GB
EGAF00001110322 cram 2.1 GB
EGAF00001110323 cram 2.1 GB
EGAF00001110324 cram 2.3 GB
EGAF00001110325 cram 2.1 GB
EGAF00001110326 cram 2.0 GB
EGAF00001110327 cram 2.1 GB
EGAF00001110328 cram 2.1 GB
EGAF00001110355 cram 2.1 GB
EGAF00001110356 cram 2.1 GB
EGAF00001110357 cram 2.1 GB
EGAF00001110358 cram 1.9 GB
16 Files (34.4 GB)